Nesbit MA - Search Results

1

Mutation-Independent Allele-Specific Editing by CRISPR-Cas9, a Novel Approach to Treat Autosomal Dominant Disease.

Christie KA, Robertson LJ, Conway C, Blighe K, DeDionisio LA, Chao-Shern C, Kowalczyk AM, Marshall J, Turnbull D, Nesbit MA, Moore CBT. Christie KA, et al. Among authors: nesbit ma. Mol Ther. 2020 Aug 5;28(8):1846-1857. doi: 10.1016/j.ymthe.2020.05.002. Epub 2020 May 8. Mol Ther. 2020. PMID: 32416058 Free PMC article.

2

Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders.

Christie KA, Courtney DG, DeDionisio LA, Shern CC, De Majumdar S, Mairs LC, Nesbit MA, Moore CBT. Christie KA, et al. Among authors: nesbit ma. Sci Rep. 2017 Nov 23;7(1):16174. doi: 10.1038/s41598-017-16279-4. Sci Rep. 2017. PMID: 29170458 Free PMC article.

3

Personalised genome editing - The future for corneal dystrophies.

Moore CBT, Christie KA, Marshall J, Nesbit MA. Moore CBT, et al. Among authors: nesbit ma. Prog Retin Eye Res. 2018 Jul;65:147-165. doi: 10.1016/j.preteyeres.2018.01.004. Epub 2018 Jan 31. Prog Retin Eye Res. 2018. PMID: 29378321 Review.

4

Post-LASIK exacerbation of granular corneal dystrophy type 2 in members of a chinese family.

Chao-Shern C, Me R, DeDionisio LA, Ke BL, Nesbit MA, Marshall J, Moore CBT. Chao-Shern C, et al. Among authors: nesbit ma. Eye (Lond). 2018 Jan;32(1):39-43. doi: 10.1038/eye.2017.265. Epub 2017 Dec 1. Eye (Lond). 2018. PMID: 29192679 Free PMC article.

5

Gene editing in the context of an increasingly complex genome.

Blighe K, DeDionisio L, Christie KA, Chawes B, Shareef S, Kakouli-Duarte T, Chao-Shern C, Harding V, Kelly RS, Castellano L, Stebbing J, Lasky-Su JA, Nesbit MA, Moore CBT. Blighe K, et al. Among authors: nesbit ma. BMC Genomics. 2018 Aug 8;19(1):595. doi: 10.1186/s12864-018-4963-8. BMC Genomics. 2018. PMID: 30086710 Free PMC article. Review.

6

CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function.

McCloskey AG, Miskelly MG, Moore CBT, Nesbit MA, Christie KA, Owolabi AI, Flatt PR, McKillop AM. McCloskey AG, et al. Among authors: nesbit ma. Peptides. 2020 Mar;125:170251. doi: 10.1016/j.peptides.2019.170251. Epub 2020 Jan 7. Peptides. 2020. PMID: 31923454

7

Evaluation of TGFBI corneal dystrophy and molecular diagnostic testing.

Chao-Shern C, DeDionisio LA, Jang JH, Chan CC, Thompson V, Christie K, Nesbit MA, McMullen CBT. Chao-Shern C, et al. Among authors: nesbit ma. Eye (Lond). 2019 Jun;33(6):874-881. doi: 10.1038/s41433-019-0346-x. Epub 2019 Feb 13. Eye (Lond). 2019. PMID: 30760895 Free PMC article. Review.

8

Gene Editing for Corneal Stromal Regeneration.

Moore T, Chao-Shern C, DeDionisio L, Christie KA, Nesbit MA. Moore T, et al. Among authors: nesbit ma. Methods Mol Biol. 2020;2145:59-75. doi: 10.1007/978-1-0716-0599-8_6. Methods Mol Biol. 2020. PMID: 32542601

9

Protein Analysis of the TGFBI^R124H Mouse Model Gives Insight into Phenotype Development of Granular Corneal Dystrophy.

Lukassen MV, Poulsen ET, Donaghy J, Mogensen EH, Christie KA, Roshanravan H, DeDioniso L, Nesbit MA, Moore T, Enghild JJ. Lukassen MV, et al. Among authors: nesbit ma. Proteomics Clin Appl. 2020 Nov;14(6):e1900072. doi: 10.1002/prca.201900072. Epub 2020 Jul 6. Proteomics Clin Appl. 2020. PMID: 32558206

10

CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting.

Courtney DG, Moore JE, Atkinson SD, Maurizi E, Allen EH, Pedrioli DM, McLean WH, Nesbit MA, Moore CB. Courtney DG, et al. Among authors: nesbit ma. Gene Ther. 2016 Jan;23(1):108-12. doi: 10.1038/gt.2015.82. Epub 2015 Aug 20. Gene Ther. 2016. PMID: 26289666 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page